Presentation TCT 2025 TCT 919: Representation of Resuscitated Out of Hospital Cardiac Arrest Patients in Landmark Cardiogenic Shock Clinical Trials - a Simulated Cohort Study Presenter: Hugh Lurcott October 27, 2025
Presentation TCT 2025 Spoiler Alert: Crossovers (Treatment Switches) can Negate the Trial Efficacy: Insights from The Ischemia Trial Presenter: John Gregson October 27, 2025
Presentation TCT 2025 The Core of Clinical Event Adjudication: Where is CEC Now and Where Do They Go Next? Presenter: Marc P. Bonaca October 27, 2025
Presentation TCT 2025 Percutaneous Coronary Angioplasty Versus Coronary Artery Bypass Grafting in the Treatment of Unprotected Left Main Stenosis: 10-year Mortality Outcomes from the Randomized NOBLE Trial Presenter: Evald H. Christiansen October 27, 2025
Presentation TCT 2025 Can Adaptive and Single-Arm Studies Meet the Needs of Key Stakeholders? Presenter: Rasha Al-Lamee October 27, 2025
Presentation TCT 2025 Drug-Coated Balloon Angioplasty with Rescue Stenting Versus Intended Stenting for the Treatment of DeNovo Coronary Artery Lesions: 3-Year Clinical Outcomes of the REC-CAGEFREE I Trial Presenter: Chao Gao October 27, 2025
Presentation TCT 2025 Case-Based Discussion: Designing a Contemporary Cardiovascular Trial Presenter: Stephan Windecker October 27, 2025
Presentation TCT 2025 TCT 447: Invisible Hearts: The Underrepresentation of Women in Cardiovascular Clinical Trials Presenter: Pablo Juan Salvadores October 27, 2025
Presentation TCT 2025 Sirolimus-Eluting Iron Bioresorbable Scaffold in Coronary Artery Disease: Two-Year Results of IRONMAN-II Randomized Controlled Trial Presenter: Lei Song October 27, 2025
Presentation TCT 2025 Modifying the Win Ratio for Noninferiority Trials: A Bridge Too Far? Presenter: Björn Redfors October 27, 2025
Presentation TCT 2025 MagicTouch Clinical Trial Program: the role of SCB in coronary revascularization Presenter: Daniela Benedetto October 27, 2025
Presentation TCT 2025 Is the WIN ratio always a “Winner”: Where It’s Useful, Where It’s Not Presenter: John Gregson October 27, 2025
Presentation TCT 2025 Comparison of Drug-Coated Versus Conventional Balloons for Treatment of Side Branches of Bifurcation Lesions: The OCVC-BIF Study Presenter: Takayuki Ishihara October 27, 2025
Presentation TCT 2025 TCT 1279: Comparison of a novel occluder versus traditional occluder in atrial septal defect: A a multi-center, randomized, parallel-controlled, non-inferiority clinical trial Presenter: Shasha Chen October 27, 2025
Presentation TCT 2025 Long Term Clinical Outcomes in Patients Treated with the Bioadaptor Compared with a Contemporary Drug Eluting Stent: The INFINITY-SWEDEHEART Randomized Trial Presenter: David Erlinge October 27, 2025
Presentation TCT 2025 Adaptive and Sequential Designs: From Concept to Execution Presenter: Graeme L. Hickey October 27, 2025
Presentation TCT 2025 Regulating with Purpose: The Role of the IRB in the Age of AI Presenter: R. Scott Wright October 27, 2025
Presentation TCT 2025 Transforming Clinical Trial Execution Using AI-Based Digital Tools (LearUp) Presenter: Carlos Granada October 27, 2025
Presentation TCT 2025 TCT 914: Impact of Visual Estimation versus Quantitative Coronary Angiography of Diameter Stenosis on Clinical Outcomes in the LIFE-BTK Trial Presenter: Hector M. Garcia-Garcia October 27, 2025
Presentation TCT 2025 TCT 910: Novel Hybrid Drug-Eluting BioStealth™ Stent for Below-the-Knee Lesions: Preclinical Results and Proposed Pivotal Clinical Trial Presenter: Terumitsu Hasebe October 27, 2025